Marinus Pharmaceuticals

Marinus, a pharmaceutical company, reformulates, develops and commercializes drugs to treat neurological, psychiatric and pain disorders.

Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of novel drugs to treat serious neurological, psychiatric, and pain disorders. The Companyâ€s lead product is a first in class therapy for epilepsy. Marinus Pharmaceuticaâ€s investors include Domain Associates, Canaan Partners, Sofinnova Ventures and Foundation Medical Partners. The Company is located in Branford, Connecticut.